Elevance Health Latest Insurer Battered By Higher Medical Costs
Elevance Health is the latest health insurance company to report higher-than-expected medical costs as third quarter profits ...
Elevance Health’s stock slumps 13% as profit dented by ‘unprecedented’ Medicaid challenges
We remain confident in the long-term earnings potential of our diverse businesses as we navigate a dynamic operating ...
Elevance Health: Strong Financial Performance and Strategic Value Create Attractive Investment Opportunity
In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Elevance Health (ELV – Research Report), with a ...
Elevance Health slashes profit forecast on persistently high medical costs
Elevance Health cut its annual profit expectation on Thursday due to increased medical costs in its government-backed plans, ...
Elevance makes a late cut to its 2024 forecast after seeing trouble in Medicaid
Elevance Health surprised Wall Street with a rare, late-year guidance cut Thursday after a jump in Medicaid costs marred its ...
Elevance Shares Dive After Insurer Faces ‘Unprecedented’ Medicaid Challenge
The company’s earnings missed expectations, the latest sign of how medical expenses are squeezing insurers’ government ...
Elevance Health price target lowered to $551 from $643 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Elevance Health (ELV) to $551 from $643 and keeps an Overweight rating on the shares.
Modern Healthcare7d
Elevance joins chorus protesting new MA star ratings
Elevance Health is "considering all of our options” to dispute the latest round of Medicare Advantage star ratings, President ...
Healthcare Finance News3d
Elevance Health 'considering options' following star ratings hit
CEO Gail Boudreaux says cut points are a large factor driving the decline of plans rated four stars or higher.